Seaport Therapeutics, Inc. Common Stock

The current price of SPTX is $20.39 — it has decreased by 2.72% since the previous close. Data as of Nov 5, 2026.

SPTX is down 2.72% over the past week, up 10.22% over the past month and up 2.77% over the past year. The price is above its 200-day moving average of $20.14.

Analysts' average 12-month price target for SPTX is $38.50, which implies 88.82% upside from the current price. Individual estimates range from $28.00 to $50.00.

Of the 9 analysts covering Seaport Therapeutics, Inc. Common Stock, 1 rates it a strong buy, 7 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Seaport Therapeutics, Inc. Common Stock has a market capitalization of $1.09B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Seaport Therapeutics, Inc. Common Stock posted a loss of $0.49 per share against an estimate of -$0.5685, beating expectations by 13.81%. Upcoming reports are listed in the earnings calendar.

Seaport Therapeutics, Inc. Common Stock has not paid any dividends over the past year.

Companies most comparable to Seaport Therapeutics, Inc. Common Stock include GH Research PLC, LB Pharmaceuticals Inc Common Stock, Rapport Therapeutics, Inc. Common Stock, Contineum Therapeutics, Inc. and MapLight Therapeutics, Inc.

In the latest trading session SPTX moved between $19.88 and $21.07, a range of 5.86% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Seaport Therapeutics, Inc. Common Stock shows a buy rating today. Technical ratings are indicators, not investment advice.

Over the past 52 weeks SPTX has traded between $14.85 and $28.38. The current price is 28.15% below its 52-week high.